Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Consensus Rating of “Hold” by Analysts
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) has been assigned an average rating of “Hold” from the seven analysts that are currently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month target […]
More Stories
Iconic Minerals (CVE:ICM) Stock Price Up 33.3% – Here’s What Happened
Iconic Minerals Ltd. (CVE:ICM – Get Free Report)’s stock price rose 33.3% on Wednesday . The stock traded as high...
Ramsay Health Care (OTCMKTS:RMSYF) Shares Up 4.7% – Should You Buy?
Shares of Ramsay Health Care Limited (OTCMKTS:RMSYF – Get Free Report) rose 4.7% on Friday . The stock traded as...
Antofagasta (OTCMKTS:ANFGF) Trading Down 0.5% – Here’s Why
Antofagasta plc (OTCMKTS:ANFGF – Get Free Report)’s share price was down 0.5% during mid-day trading on Friday . The company...
JPMorgan BetaBuilders U.S. Aggregate Bond ETF (NYSEARCA:JAGG) Trading 0.1% Higher – Here’s Why
Shares of JPMorgan BetaBuilders U.S. Aggregate Bond ETF (NYSEARCA:JAGG – Get Free Report) traded up 0.1% on Friday . The...
Loungers (LON:LGRS) Stock Price Down 0.6% – Here’s Why
Loungers plc (LON:LGRS – Get Free Report)’s share price dropped 0.6% on Friday . The stock traded as low as...
FirstRand (OTCMKTS:FANDF) Trading Down 5% – What’s Next?
Shares of FirstRand Limited (OTCMKTS:FANDF – Get Free Report) dropped 5% on Friday . The stock traded as low as...